Tuberculosis (TB) Diagnostics Market size was valued at USD 2.03 billion in 2022 and is expected to reach USD 3.33 billion By 2030 and grow at a CAGR of 6.4% over the forecast period of 2023-2030.

The Tuberculosis (TB) Diagnostics Market is a crucial component in the global fight against this highly infectious disease. TB remains a significant public health concern, especially in developing countries where resources for early detection and treatment are limited. Therefore, the need for accurate and efficient diagnostic tools is paramount to control the spread of TB and reduce its impact on individuals and communities.

In recent years, there have been remarkable advancements in TB diagnostics, driven by technological innovations and increased investments in research and development. Traditional diagnostic methods like sputum smear microscopy, which rely on visual examination of patient samples under a microscope, have limitations in terms of sensitivity and specificity. However, newer molecular techniques such as nucleic acid amplification tests (NAATs) have revolutionized TB diagnosis by providing faster and more accurate results.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2983

NAATs, including polymerase chain reaction (PCR) assays and line probe assays (LPAs), detect the genetic material of Mycobacterium tuberculosis (the bacterium causing TB) directly from patient These advancements in TB diagnostics have greatly improved the ability to detect and diagnose TB, leading to earlier treatment and better outcomes for patients.

KEY MARKET SEGMENTS

By Type:

• Culture-Based Diagnostics
• Sputum Smear Microscopy
• Rapid Molecular Diagnostics

By End User:

• Hospitals
• Diagnostics
• Laboratories

Major Players Listed in the Report are as Follows:

Akonni Biosystems Inc., Alere Inc., Par Pharmaceutical, Lionex GmbH, Creative Diagnostics, Abbott Laboratories, BioMerieux SA, Cepheid, Hologic Inc., F. Hoffmann-La Roche Ltd and other players

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)